Clinical Trial Update: Effect of Sitagliptin on Postprandial Lipoprotein Metabolism [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluates the effect of sitagliptin on postprandial lipoprotein metabolism in adults with type 2 diabetes. The study sponsored by Ludwig-Maximil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: TERMINATED